|

Paclitaxel/Paclitaxel-albumin/Paclitaxel liposome Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Qilu Hospital of Shandong University1

Indications

  • Advanced Gastric or Gastroesophageal Junction Adenocarcinoma1
  • Cancer1

Other1 trial

Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.